ArticleBritish journal of haematology2024

Gemcitabine plus pembrolizumab after checkpoint blockade failure as a strategy in multiply relapsed Hodgkin lymphoma.

Robert Stuver et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.